ScopeEndo is an advanced artificial intelligence-powered software solution engineered to enhance diagnostic precision and clinical workflow during gastrointestinal endoscopy. By combining state-of-the-art medical computer vision algorithms with optimized edge AI architecture, ScopeEndo analyzes high-definition video frames in real time without operational latency, assisting endoscopists during critical procedures.

The solution delivers high-sensitivity Computer-Aided Detection (CADe), identifying subtle polyps, early-stage adenomas, and sessile serrated lesions that may be overlooked during routine colonoscopy. This substantially supports higher Adenoma Detection Rates (ADR) while reducing practitioner fatigue. In addition, ScopeEndo provides automated lesion size estimation, delivering objective quantitative metrics to support informed decisions regarding endoscopic resection and subsequent clinical pathways.

Engineered for seamless integration with existing endoscopic infrastructure, ScopeEndo achieved medical device GMP certification and an official manufacturing license in early 2026. Through rigorous clinical validation and multi-center proof-of-concept trials with leading university hospitals, ScopeEndo is establishing a new standard of reliability and clinical efficiency in modern digestive endoscopy.